北京科兴中维生物技术有限公司（Sinovac Life Sciences Co., Ltd.）是科兴控股（香港）有限公司投资设立的生物高新技术企业，于2009年注册成立，注册资本2400万美元。公司位于中关村科技园大兴生物医药产业基地，是中关村高新技术企业、中关村金种子企业。

China’s medical products regulator approves Sinovac Biotech’s COVID-19 vaccine for public use. This marks the second vaccine authorized in China, following an earlier approval for another developer’s shot. The move expands vaccine availability as China manages ongoing pandemic response efforts.

Feb 2021MTV LebanonNews article

China approves broader use of the Sinovac coronavirus vaccine, allowing administration to populations beyond previously authorized high-risk and priority groups under emergency clearance. The move follows the vaccine’s domestic production and initial emergency approvals.

Feb 2021Yahoo Finance SingaporeNews article

Sinovac raises **$515 million** to expand production of its COVID-19 vaccine candidate while its **Phase 3 trials progress**. The funding supports doubling manufacturing capacity as developers scale up ahead of potential regulatory approvals. Investors back the effort amid global demand for vaccines.

Dec 2020Fierce PharmaNews article

Sinovac Biotech raises $515 million to expand production of its COVID-19 vaccine. The funding comes from a local investor and aims to double manufacturing capacity. The company anticipates releasing efficacy data for its vaccine candidate this month.

Dec 2020Business RecorderNews article